Regeneron, Sanofi Announce Approval of Praluent for Treatment of Hypercholesterolemia in EU
September 28, 2015 at 05:20 AM EDT
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (NYSE: SNY) today announced that the European Commission (EC) has granted ...